HST Global, Inc.

Equities

HSTC

US40432E2028

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 03:10:38 2024-04-26 pm EDT			5-day change	1st Jan Change
1.11 ^USD	+18.09%		-0.89%	+82.72%

Apr. 05	HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	HST Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021

March 04, 2022 at 02:56 pm EST

HST Global, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 0.14836 million compared to USD 0.208992 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.04 a year ago.

Latest news about HST Global, Inc.

HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 05	CI
HST Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 07	CI
HST Global, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
HST Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-31	CI
HST Global, Inc. Auditor Raises 'Going Concern' Doubt	23-01-30	CI
HST Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
HST Global, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-07-26	CI
HST Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-04	CI
HST Global, Inc. Auditor Raises 'Going Concern' Doubt	22-03-03	CI
HST Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-08	CI
Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13	CI
Hst Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-13	CI
HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
HST Global, Inc. Auditor Raises 'Going Concern' Doubt	21-04-13	CI
Hst Global, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-08-10	CI
Hst Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-15	CI
Hst Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-09	CI
Hst Global, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-19	CI
Hst Global, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-20	CI
Hst Global, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-16	CI
Hst Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-02	CI
HST Global, Inc. Auditor Raises 'Going Concern' Doubt	15-03-19	CI

Chart HST Global, Inc.

Duration

Period

More charts

Company Profile

HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
HST GLOBAL, INC.	+82.72%	5.83M
IQVIA HOLDINGS INC.	+2.36%	42.75B
LONZA GROUP AG	+47.75%	41.61B
MODERNA, INC.	+12.37%	41.34B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.51%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-23.43%	18.12B
MEDPACE HOLDINGS, INC.	+30.52%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.77%	11.76B
UNITED THERAPEUTICS CORPORATION	+8.40%	11B

Other Biotechnology & Medical Research